Human subjects drank coffee containing 412 mol of chlorogenic acids, and plasma and urine were collected 0 to 24 h after ingestion and were analyzed by high-performance liquid chromatographymass spectrometry. Within 1 h, some of the components in the coffee reached nanomole peak plasma concentrations (C max ), whereas chlorogenic acid metabolites, including caffeic acid 
Coffee is widely consumed throughout the world, and the beverage contains high levels of chlorogenic acids with a single serving providing between 20 and 675 mg depending on the type of roast and the volume consumed (Clifford, 1999) . Coffee can be a major dietary source of chlorogenic acids, which possess strong antioxidant activity (Stalmach et al., 2006) , with some regular drinkers potentially ingesting in excess of 1 g on a daily basis. Chlorogenic acids are a group of compounds comprising hydroxycinnamates, such as caffeic acid, ferulic acid, and p-coumaric acid, linked to quinic acid to form a range of conjugated structures known as caffeoylquinic acids (CQA), feruloylquinic acids (FQA), and p-coumaroylquinic acids ( p-CoQA) (Clifford, 1999) . Coffee contains many isomers of these compounds depending on whether the hydroxycinnamate is attached to 3-, 4-, or 5-position of the quinic moiety. There are also di-caffeoylquinic acids (diCQA) and caffeoylquinic acid lactones (CQAL) (Fig. 1) .
The metabolic fate of 5-CQA, which is the major chlorogenic acid in coffee, has been investigated in animal models. Choudhury et al. (1999) did not detect any CQA or its metabolites in urine collected from rats 0 to 24 h after ingestion of an acute dose. In contrast, a variety of conjugated metabolites, mainly glucuronides and/or sulfates of caffeic acid and ferulic acid, were identified in the plasma of rats after feeding 5-CQA (Azuma et al., 2000) . Hippuric acid, 3-hydroxyphenylpropionic acid, and m-coumaric acid, thought to be derived from colonic microbial degradation of 5-CQA, have been detected in both plasma and urine of rats (Gonthier et al., 2003) . The presence of isoferulic acid was reported in the mesenteric plasma of rats perfused in situ with 5-CQA (Lafay et al., 2006) .
A limited number of studies have investigated the bioavailability of coffee chlorogenic acids in human subjects. Nardini et al. (2002) reported an increase of conjugated caffeic acid in human plasma, reaching a maximum concentration 1 h after the ingestion of 200 ml of coffee. Increased amounts of ferulic acid, isoferulic acid, vanillic acid, dihydroferulic acid, hippuric acid, and 3-hydroxyhippuric acid were detected in urine samples of five male subjects, after three ingestions of two cups of coffee at 4-h intervals (Rechner et al., 2001 ). More recently, Monteiro et al. (2007) reported the presence of a range of CQAs and diCQAs in plasma with an overall C max of 7.7 Ϯ 2.5 M occurring 2.3 Ϯ 1.3 h after acute ingestion of coffee. Despite these high levels in the circulatory system, CQAs were not detected in urine that contained phenolic acids. However, in a subsequent publication, the same group reported the excretion of 4-and 5-CQA in the urine of some but not all of the volunteers after the consumption of coffee (Farah et al., 2008) . The chlorogenic acids were also detected in plasma collected before ingestion of the coffee. Information on the bioavailability and metabolic fate of dietary phenolics and flavonoids is a key part of the equation in understanding their potential effects on human health. The aim of this study was to use HPLC-PDA-MS n to identify and quantify compounds circulating in the blood stream and excreted in urine after the acute consumption of coffee by healthy human subjects.
Materials and Methods
Chemicals. Ferulic acid, 5-CQA, dihydrocaffeic acid, sinapic acid, and L-ascorbic acid were purchased from Sigma-Aldrich Co. Ltd. (Poole, Dorset, UK). Caffeic acid was obtained from AASC Ltd. (Southampton, UK), and dihydroferulic acid was from Alfa Aesar (Heysham, Lancashire, UK). EDTA and HPLC grade formic acid were purchased from Fisher Scientific Ltd. (Loughborough, Leicestershire, UK), methanol and acetonitrile were obtained from Rathburn Chemicals (Walkerburn, Scotland), and acetic acid was from VWR International Ltd. (Poole, Dorset, UK).
3-and 4-caffeoylquinic acid lactones, 3-and 4-␤-O-glucuronidated ferulic, isoferulic, caffeic, dihydrocaffeic, dihydroferulic, and dihydro(iso)ferulic acids, and 3-and 4-O-sulfated ferulic, caffeic, dihydrocaffeic, and dihydroferulic acids were synthesized by R. Fumeaux, C. Menozzi-Smarrito, and D. Barron (unpublished data) (Nestlé Research Centre).
Glycine Conjugates Synthesis. Feruloylglycine. 4-Methylmorpholine (1.52 g) was added to the solution of ferulic acid (0.97 g), methyl glycinate hydrochloride (0.63 g), 1-hydroxybenzotriazole (0.68 g), and O- (benzotriazol-1-yl avoiding moisture. The reaction mixture was poured into 150 ml of cold water and extracted with ethyl acetate three times. The organic phases were combined and washed successively with 1 M HCl, water, saturated sodium bicarbonate solution, water, and brine. The ethyl acetate extract was dehydrated with anhydrous sodium sulfate, before being dried in vacuo to give a syrup (0.72 g; yield 53%). Because the syrup was almost pure methyl feruloylglycine, this product was subjected to the next reaction without further purification.
1 H-NMR (CDCl 3 ): ␦ ϭ 3.79 (s, 3), 3.92 (s, 3), 4.18 (d, 2), 5.82 (s, 1), 6.07 (t, 1), 6.31 (d, 1), 6.90 (d, 1), 7.00 (d, 1), 7.06 (dd, 1), 7.57 (d, 1). The 0.72 g of methyl feruloylglycine was dissolved in 30 ml of methanol containing 5.9 ml of NaOH (1 M) and stirred overnight at room temperature. The resulting mixture was concentrated in vacuo. The residue was dissolved in 30 ml of water, acidified with 1 M HCl to pH 2, and extracted with ethyl acetate four times. The ethyl acetate extracts were combined, washed with a small amount of water, dried with anhydrous sodium sulfate, and reduced to dryness in vacuo to give a solid. The solid was recrystallized from acetonitrile to give fine needles of feruloylglycine. Yield: 0.56 g (82% 12.63 (b, 1) . All NMR spectra were recorded on an ECA-500 spectrometer (JEOL, Tokyo, Japan).
Feeding Study Design. Participants and inclusion criteria. The criteria for volunteers to participate in the study were to be in good health, nonsmoker, and not pregnant. Eleven volunteers participated in the study (eight male and three female) and were aged 19 to 35 years, with an average height of 1.70 Ϯ 0.13 m (mean Ϯ S.D.), an average weight of 70.6 Ϯ 11.5 kg, and an average body mass index of 24.3 Ϯ 2.3 kg/m.
Trial design. The study and protocol were reviewed by Glasgow Royal Infirmary NHS Research Ethics Committee. The volunteers followed a low polyphenol diet for 48 h before the beginning of the study. On the night preceding the trial, the subjects stopped consuming food after dinner (8:00 PM) and came to the trial unit at 8.30 AM the next day in a fasted state. Water was the only liquid allowed ad libitum. The 200-ml coffee beverage was made as described below. The participants were encouraged to drink the beverage within 5 min after it reached a suitable temperature for consumption. All urine excreted over 24 h was collected over the following periods: 0 to 2 h, 2 to 5 h, 5 to 8 h, and 8 to 24 h, and blood samples were collected in heparin tubes before (0 h) and after ingestion at 0.5, 1, 1.5, 2, 3, 4, 6, 8, and 24 h.
A standard lunch, containing low levels of phenolic and polyphenolic compounds, was provided after the 3-h samples were collected. The amount consumed was not limited, water was available all day, and the subjects were encouraged to drink. After the 8-h samples were collected, the volunteers remained on the low-phenolic diet until the next morning, before collection of the 24-h time point samples. The volumes of urine excreted were measured, and aliquots were stored at Ϫ80°C, and, likewise, plasma samples were subdivided into 1-ml aliquots that were stored at Ϫ80°C before analysis.
Coffee, Plasma, and Urine Analyses. The coffee fed to the volunteers was an instant coffee supplied by Nestlé Research Centre. Coffee samples were prepared by adding 200 ml of boiled distilled water to 3.4 g of powdered instant coffee, and aliquots were stored at Ϫ80°C before analysis. Samples were defrosted and centrifuged at 16,110g for 3 min at 4°C and diluted 50-fold with distilled water, and 100-l aliquots were analyzed in triplicate by HPLC-PDA-MS n . Urine samples were defrosted and centrifuged at 16,110g for 3 min at 4°C, before the triplicate analysis of 20-l aliquots by HPLC-PDA-MS n . Plasma samples were defrosted and were extracted based on the method of Day et al. (2001) . Plasma (450 l), acidified with 13.5 l of 50% aqueous formic acid, was added dropwise to 1125 l of acetonitrile, to which 50 l of 10% (m/v) ascorbic acid containing 0.5 mM EDTA had been added and 1 g of sinapic acid that was used as an internal standard. Samples were vortexed for 30 s every 2 min over a 10-min period before centrifuging at 1500g for 20 min at 4°C. The supernatant was decanted, and the pellet was re-extracted with 1125 l of methanol. After centrifugation, the two supernatants were combined and reduced to dryness under a stream of nitrogen at 35°C. The dried samples were then resuspended in 250 l of aqueous formic acid (0.1%) containing 10% methanol and centrifuged at 4°C for 20 min at 16,110g in a 0.2-m Eppendorf filter (Alltech Associates Applied Sciences Ltd., Lancashire, UK). Duplicate 100-l volumes were analyzed by HPLC-PDA-MS n . Extraction efficiency experiments were performed, and typical values of 55 Ϯ 1.5% were achieved for sinapic acid. Extraction efficiencies were also determined for 5-CQA, caffeic acid, ferulic acid, dihydrocaffeic, and dihydroferulic acids, and for 3-and 4-CQA lactones. Ratios of the individual recoveries relative to sinapic acid were computed and used as correction factors in the quantification of metabolites in the plasma samples.
HPLC-PDA-MS n . Chlorogenic acids and the related compounds were analyzed using a Surveyor HPLC with a PDA detector and a LCQ Duo ion trap mass spectrometer fitted with an electrospray interface (Thermo Fisher Scientific, Waltham, MA). Separations were performed at 40°C using a SYNERGI 4 m POLAR-RP 250 ϫ 4.6 mm i.d. reverse-phase column (Phenomenex, Macclesfield, UK). Injections were carried out with an autosampler maintained at 4°C. The mobile phase was pumped at a flow rate of 1 ml/min. The column eluate initially passed through the PDA detector and was then split, and 0.3 ml/min was directed to the mass spectrometer with ESI operating in full-scan negative ionization mode (100 -1000 m/z). Analyses of coffee, plasma, and urine samples were initially carried out using full-scan, data-dependant MS 2 scanning from m/z 100 to 1000. The tuning of the mass spectrometer was optimized by infusing a standard of ferulic acid, dissolved in the initial HPLC mobile phase, into the source at a flow rate of 0.3 ml/min. Capillary temperature was 300°C; sheath gas and auxiliary gas were 80 and 60 units/min, respectively; source voltage was 3.0 kV; and collision energy was set at 35%.
Separation of coffee chlorogenic acids was achieved on a 70-min gradient of 5 to 25% acetonitrile in 0.1% aqueous formic acid. After separation, hydroxycinnamates were detected and quantified with the PDA at 325 nm, and identification was confirmed by mass spectrometry using consecutive reaction monitoring. Mean data are expressed as mol Ϯ S.E. (n ϭ 3) of 5-CQA equivalents for the CQAs, FQAs, di-CQAs, and p-CoQAs, and as mol Ϯ S.E. (n ϭ 3) of 3-CQAL and 4-CQAL for the respective lactones quantified.
Plasma and urine were analyzed using a 40-min, 5 to 16% gradient of acetonitrile in 0.5% aqueous acetic acid. After separation, hydroxycinnamates and metabolites were quantified using selective ion monitoring (SIM), based on the calibration curves of the corresponding standard. Sulfated ferulic, isoferulic, caffeic, dihydroferulic, and dihydrocaffeic acids were quantified based on the SIM calibration curves of the respective O-sulfated standards. Sulfated 3-and 4-caffeoylquinic acid lactones were quantified based on the SIM calibration curves for 3-and 4-CQAL, respectively. Feruloylglycine was quantified based on the calibration curve of ferulic acid at 325 nm, because the glycine derivative, like ferulic acid, had a max at this wavelength. Quantification of FQAs was based on the SIM calibration curve of 5-CQA. Glucuronidated isoferulic acid, dihydroferulic acid, dihydro(iso)ferulic acid, and dihydrocaffeic acid were quantified based on SIM calibration curves of authentic isoferulic-, dihydroferulic-, and dihydrocaffeic acid-O-glucuronides, respectively. Data are expressed as mean values Ϯ S.E. (n ϭ 11), in micromole for urine and nanomole for plasma.
Calibration curves of standards used to quantify chlorogenic acids and derivatives in various samples were drawn from the analysis of 5-l volumes at concentrations ranging from 0.1 to 100 ng/l (n ϭ 7) for coffee samples and 0.2 to 20 ng/l (n ϭ 5) for plasma and urine samples. Coefficients of linearity for the calibration curves were typically R 2 Ͼ 0.99. The limits of detection as monitored on PDA (at 325 nm for chlorogenic acids and hydroxycinnamates, and 280 nm for dihydrocaffeic acid and dihydroferulic acid) and SIM were determined by analysis in triplicate of standards at low concentrations. Typical limits of detection for PDA were 0.5 ng [coefficient of variation (CV) 4.6 -22%], and 0.1 ng (CV 5.6 -33%) for SIM, except for isoferulic acid where 5 ng (CV 23%) was obtained with SIM at m/z 193, because the acid content of the mobile phase suppresses ionization (Clifford et al., 2007) .
Pharmacokinetic Analysis of Chlorogenic Acids and Their Metabolites in Plasma. Maximum plasma concentration of the metabolites from 0 to 24 h
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at ASPET Journals on June 15, 2017 dmd.aspetjournals.org postdose was defined as C max with T max being the time at which C max was reached. The elimination half-life for the metabolites was computed by using the following formula: T 1/2 ϭ 0.693/Ke, where Ke is the slope of the linear regression of the plasma metabolite concentrations. Area-under-the-curve (AUC) calculations were determined using a Kinetica software package (Thermo Fisher Scientific).
Results
Analysis of Coffee. The 200-ml serving of instant coffee ingested by the human subjects contained 412 mol of chlorogenic acids with CQAs comprising 65% of the total, FQAs comprising 16% of the total, CQALs comprising 14% of the total, di-CQAs comprising 3% of the total, and p-CoQA comprising 2% of the total. The main compound, 5-CQA, accounted for 44% of the CQAs and 29% of the total content of chlorogenic acids (Table 1) .
Analysis of Plasma and Urine. A total of 21 metabolites, principally sulfates and glucuronides, were identified in the 0-to 24-h plasma and urine samples of the human volunteers after the ingestion of coffee containing 412 mol of chlorogenic acids. The identifications, summarized in Table 2 , were achieved using HPLC-MS 3 in the consecutive reaction monitoring mode. This result consisted of selecting a negatively charged molecular ion ([M-H] Ϫ ) of interest for further fragmentation. The resulting MS 2 and MS 3 daughter ions were then compared with the fragmentation of either the available standards or, in the case of the chlorogenic acids, to their detailed, published MS n fragmentation patterns (Clifford et al., 2003 (Clifford et al., , 2005 . The identity of metabolites of chlorogenic acids in plasma and urine samples were also ascertained by comparing their retention time with those of 3-Oand 4-O-sulfate and glucuronide standards. Typical HPLC-MS-SIM traces obtained with plasma and urine are presented in Figs. 2 and 3 , respectively, and the identifications of the 21 numbered peaks, which are summarized in Table 2 , are based on the following criteria.
Peaks 1 and 4 (R t ϭ 7.2 and 11.2 min) could be detected in the 0-to 2-h urine samples. These compounds had a [M-H] Ϫ at m/z 433, which produced an ion at m/z 353 on MS 2 . The MS 3 fragmentation patterns produced ions at m/z 191, 179, 135, corresponding to that of 3-Ocaffeoylquinic acid, and m/z 191, 179, 173, 135, characteristic of 4-O-caffeoylquinic acid (Clifford et al., 2003) . Thus, these compounds were identified as O-sulfates of 3-and 4-O-caffeoylquinic acid.
Peak 2 (R t ϭ 10.
produced an ion at m/z 181, an 80 atomic mass units (amu) loss indicative of the cleavage of a sulfate moiety. MS 3 produced daughter ions at m/z 137 and 119, characteristic of the fragmentation pattern of dihydrocaffeic acid. Based on cochromatography with a reference compound and a matching MS 3 spectrum, peak 2 is dihydrocaffeic acid-3-O-sulfate, which was found in both urine and plasma.
Peak 3 (R t ϭ 11.1 min) was identified by cochromatography with a standard of dihydrocaffeic acid-3-O-glucuronide. The [M-H] Ϫ at m/z 357 produced a MS 2 daughter ion at m/z 181, a 176 amu loss of a glucuronide unit, as well as fragments at m/z 175 and 113, which are characteristic of the presence of a glucuronic acid moiety. Dihydrocaffeic acid-3-O-glucuronide was detected in urine but not in plasma.
Peaks 5 and 7 (R t ϭ 11.7 and 12.8 min) had [M-H] Ϫ at m/z 259 and yielded an ion at m/z 179 upon MS 2 . The 80-amu loss of a sulfate group and MS 3 producing an ion at m/z 135 indicate that both peaks are caffeic acid sulfates. Cochromatography and MS fragmentation of reference compounds showed peak 5 is caffeic acid-4-O-sulfate and peak 7 is caffeic acid-3-O-sulfate. Although these two compounds were detected in both urine and plasma samples, only trace, nonquantifiable amounts of caffeic acid-4-O-sulfate were present in plasma.
Peak 6 (R t ϭ 12.1 min), which was detected in urine and plasma, produced a [M-H] Ϫ at m/z 275, which on MS 2 yielded an ion at m/z 195 (loss of 80 amu). The ions produced on MS 3 (m/z 177, 151, 136, 135, 123, and 119) were characteristic of a standard of dihydroferulic acid. Through cochromatography with a standard, peak 6 was identified as dihydroferulic acid-4-O-sulfate.
Peak 8 (R t ϭ 13.5 min) cochromatographed and had a MS 2 spectrum (m/z 181 3 m/z 137 and 119) which matched that of dihydrocaffeic acid. This metabolite was present in plasma, with only trace amounts detected in urine.
Peaks 9 and 14 (R t ϭ 13.9 and 17.7 min) had a [M-H] Ϫ at m/z 371, which upon MS 2 fragmentation, yielded ions at m/z 195, 175, and 113 (M-176 loss of a glucuronyl unit). In keeping with this fragmentation pattern, peak 9 cochromatographed with dihydroferulic-4-Oglucuronide, and peak 14 cochromatographed with dihydro(iso)ferulic-3-O-glucuronide. Dihydroferulic-4-O-glucuronide was present in urine but occurred in only trace, nonquantifiable amounts in plasma. Dihydro(iso)ferulic-3-O-glucuronide was detected in urine but not in plasma.
Peaks 10 and 13 (R t ϭ 14.5 and 16.9 min) both had a [M-H] Ϫ at m/z 273, which yielded a MS 2 ion at m/z 193 with a loss of 80 amu. With peak 10, MS 3 of the m/z 193 ion produced a mass spectrum corresponding to that of ferulic acid (m/z 178, 149, 134), whereas peak 13 yielded an ion at m/z 178, indicative of isoferulic acid (m/z 178). Therefore, peak 10 was identified as ferulic acid-4-O-sulfate, and peak 13 was established as isoferulic acid-3-O-sulfate. These compounds were present in urine and plasma samples, with only traces of isoferulic acid-3-O-sulfate detected in plasma.
Peak 11 (R t ϭ 15.4 min) cochromatographed with a standard of 5-CQA and had a MS 2 spectrum at m/z 191. This compound was present in very low quantities in plasma, but it was not detected in urine.
Peaks 12, 19, and 21 (R t ϭ 16.5, 24.6, and 27.4 min) had the same HPLC retention times as the FQAs detected in the instant coffee. Their MS 2 fragmentation patterns also corresponded to those described by Clifford et al. (2003) cochromatographed with a standard of isoferulic-3-O-glucuronide. This glucuronide accumulated in urine but was only present in plasma in trace amounts that could not be quantified reliably. Peak 16 (R t ϭ 21.9 min) was identified as feruloylglycine based on cochromatography with a reference compound and on its [M-H] Ϫ at m/z 250 and the MS 2 fragmentation profile with ions at m/z 206, 191, 177, 149, and 100, which corresponded to the fragmentation pattern of the standard. The feruloylglycine peak was detected in urine but not in plasma.
Peaks 17 and 18 (R t ϭ 22.4, 22.9 min) were detected in both urine and plasma and had a [M-H] Ϫ at m/z 415, which upon MS 2 produced fragments at m/z 335, with the 80-amu cleavage of a sulfate moiety. Further fragmentation yielded ions at m/z 161 and 135 corresponding to the fragmentation of 3-and 4-CQAL. Thus, peaks 17 and 18 were identified as O-sulfates of 3-and 4-CQAL, respectively. The lack of standards prevented the positions of the sulfate group on the lactones from being determined.
Peak 20 (R t ϭ 26.4 min) cochromatographed with a standard of dihydroferulic acid and had a [M-H] Ϫ at m/z 195, which produced MS 2 ions at m/z 177, 151, 136, 135, 123, and 119. Dihydroferulic acid was identified and quantified in both plasma and urine.
Quantification of Plasma Hydroxycinnamate Derivatives. Typical HPLC-SIM traces obtained with plasma samples are illustrated in Fig. 2 . A total of 12 hydroxycinnamate derivatives, mostly metabolites, were quantified in plasma after the ingestion of the instant coffee containing 412 mol of chlorogenic acids. The pharmacokinetic parameters are summarized in Table 3 , and pharmacokinetic profiles of circulating compounds are illustrated in Fig. 4 . Maximum postingestion C max values ranged from 6 nM for 5-FQA to 385 nM for dihydroferulic acid, whereas the duration for T max extended from 0.6 h (ferulic acid-4-O-sulfate, 3-CQAL-O-sulfate) to 5.2 h (dihydrocaffeic acid) after coffee ingestion. The main compounds found in the postprandial plasma samples were free and sulfated conjugates of dihydroferulic acid and dihydrocaffeic acids with C max values of 41 to 385 nM. The T max for these compounds was in a narrow range from 4.7 to 5.2 h, which is indicative of absorption in the large intestine. Much shorter duration T max values, 0.6 to 1.0 h, demonstrating small intestine absorption, were obtained with 5-CQA, the two CQAL-Osulfates, and the three FQAs. All of these components had a relatively low C max with values of 2.2 to 27 nM (Table 3) .
Most compounds were eliminated rapidly from the circulatory system with T 1/2 values ranging from 0.3 to 1.9 h for the CQAL-Osulfates, 5-CQA, the FQAs, and caffeic acid-3-O-sulfate. From the pharmacokinetic profile of ferulic acid-4-O-sulfate, it is evident that the metabolite has an unusual biphasic profile (Fig. 4) , with an initial C max of 76 nM, reached 0.6 h after the consumption of coffee, followed by a second C max of 46 nM, with a C max at 4.3 h. This extended T max was associated with a T 1/2 of 4.9 h, which was similar to that observed with dihydroferulic acid-4-O-sulfate (4.7 h) and dihydroferulic acid-3-O-sulfate (3.1 h). Most other of the compounds were eliminated from the circulatory system much more rapidly with T 1/2 values ranging from 0.4 to 1.9 h for caffeic acid-3-O-sulfate, the CQAL sulfates, and the FQAs, and 0.3 h for 5-CQA (Table 3) . Traces of 5-CQA were also detected in plasma, with a C max of 2.2 Ϯ 1.0 nM and a T max of 1.0 Ϯ 0.2 h. The only other compounds initially present in the beverage and recovered, seemingly unmetabolized, in the plasma samples were the three FQAs, all of which had a low C max and short duration values for both T max and T 1/2 , suggestive, like 5-CQA, of low-level absorption in the small intestine. Another point of note is the fact that the free acid, dihydroferulic acid, as opposed to the more typical glucuronide or sulfated metabolites, was the principal compound to accumulate in plasma which also contained dihydrocaffeic acid in lower amounts (Table 3) .
Ferulic acid-4-O-sulfate, dihydrocaffeic acid-3-O-sulfate, and dihydroferulic acid-4-O-sulfate were detected in the 0-h plasma of some, but not all subjects. The respective average 0-h concentrations were 1.1 Ϯ 1.1, 3.1 Ϯ 2.1, and 6.4 Ϯ 2.8 nM, which are 25-to 100-fold lower than their C max values attained after coffee consumption (Table 3) .
Quantification of Urinary Hydroxycinnamate Derivatives. A total of 17 hydroxycinnamate derivatives, mainly metabolites, were identified in the urine of the 11 human volunteers. Typical HPLC-SIM traces obtained with the urine samples are illustrated in Fig. 3 , and quantitative data are presented in Table 4 . 
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The total amount of chlorogenic acid derivatives and metabolites excreted in the 24-h urine was 120 Ϯ 17 mol, accounting for 29 Ϯ 4% of the 412 mol total intake ( Table 4 ). The only unmetabolized chlorogenic acids appearing in urine that were initially present in the coffee were small quantities of 3-, 4-, and 5-FQA, which were excreted in quantities equivalent to 4.9% of FQA intake. Almost 50% of the excretion, 57 Ϯ 16 mol, occurred during the 5-to 8-h period after ingestion of the coffee. This result is principally due to the excretion of dihydrocaffeic acid-3-O-sulfate, feruloylglycine, dihydroferulic acid-4-O-sulfate, ferulic acid-4-O-sulfate, dihydroferulic acid, and dihydroferulic acid-4-O-glucuronide (51.0 mol). There was a trend for proportionally more excretion in the 5-to 24-h time period of compounds such as dihydrocaffeic acid-3-O-sulfate and dihydroferulic acid-4-O-sulfate, which, on the basis of their T max (Table 3) , were absorbed in the large intestine. Ferulic acid-4-Osulfate, which exhibited a biphasic plasma profile with an extended T 1/2 ( Fig. 3; Table 3 ), also exhibited delayed excretion. FQAs and 3-and 4-CQAL-O-sulfates, which accounted for 4.4 Ϯ 0.4% of the 120 mol excreted, appeared in urine predominantly 0 to 5 h after coffee intake (Table 4) . Other metabolites that were excreted in relatively small amounts were the sulfates of caffeic acid, isoferulic acid, and the CQALs, along with the glucuronides of dihydrocaffeic acid, dihydroferulic acid, and dihydro(iso)ferulic acid ( Table 4) .
As noted with plasma samples, O-sulfated ferulic acid, caffeic acid, dihydroferulic acid, and dihydrocaffeic acid, and feruloylglycine and O-glucuronides of isoferulic and dihydroferulic and dihydro(iso)ferulic acids were detected in some of the 0-h urine samples, with concentrations ranging from 0.3 Ϯ 0.1 M for dihydro(iso)ferulic acid-3-O-glucuronide to 5.6 Ϯ 1.4 M for dihydrocaffeic acid-3-Osulfate. In general, these are quantities well below the amounts excreted 0 to 24 h after drinking the instant coffee (Table 4) .
Discussion
During their passage through the body there is extensive metabolism of chlorogenic acids after the ingestion of coffee. The 0-to 24-h excretion of the parent compounds and their metabolites corresponded to 29.1% of intake (Table 4 ). This result indicates that the coffee chlorogenic acids are bioavailable to a much greater extent than many other dietary flavonoids and phenolic compounds (Manach et al., 2005) . Within 1 h of intake, as a result of absorption in the small 
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at ASPET Journals on June 15, 2017 dmd.aspetjournals.org intestine, low plasma C max values were obtained with unmetabolized 5-CQA, three FQAs, two sulfated CQALs, and, at higher concentrations, caffeic acid-3-O-sulfate and ferulic acid-4-O-sulfate (Table 3 ; Fig. 4 ). More substantial absorption occurred, presumably from the large intestine, with 4.7 to 5.2 h C max values being attained for dihydroferulic acid-4-O-sulfate, dihydrocaffeic acid-3-O-sulfate, unmetabolized dihydroferulic acid, and dihydrocaffeic acid. Exactly where these metabolic events occur and in what sequence requires further experimentation, among other things, with individual chlorogenic acids. However, the current data provide a number of indications that serve as the basis for at least a working model of the metabolic pathways involved (Fig. 5) . Despite being major components in the coffee, only trace amounts of one of the CQAs, 5-CQA, appears in the circulatory system. In contrast, plasma contained low levels of all three FQAs with absorption occurring, as with 5-CQA, in the small intestine. As illustrated in Fig. 5 , 5-CQA, which is stable when incubated with gastric juice (Rechner et al., 2001) , and the other CQAs are probably subjected to the action of esterases in the wall of the small intestine (Buchanan et al., 1996; Andreasen et al., 2001) , releasing caffeic acid that is converted to caffeic acid-3-O-sulfate which then enters the bloodstream. It is possible that 3-and 4-CQAL, which appear as sulfates in plasma, could also be hydrolyzed in the small intestine and contribute to the caffeic acid pool. The appearance of ferulic acid-4-O-sulfate in plasma could be the result of the FQAs following a parallel pathway being converted to ferulic acid and then to ferulic acid-O-sulfate, although methylation of caffeic acid via catechol-O-methyltransferase, as well as the conversion of CQAs to FQAs, could also contribute to the ferulic acid pool (Fig. 4) . Although the small intestine is a major site of sulfation in vivo for quercetin Mullen et al., 2006) , most ferulic acid passes across the small intestine in the free acid (Poquet et al., 2008) , implying that sulfation occurs mainly in the liver.
The pharmacokinetic data in Table 3 indicates the appearance in the circulatory system of dihydrocaffeic acid, dihydrocaffeic acid-3-Osulfate, dihydroferulic acid, and dihydroferulic acid-4-O-sulfate ϳ5 h after drinking coffee. This result indicates colonic microflora-mediated conversion of CQAs to caffeic acid and dihydrocaffeic acid, and FQAs to ferulic acid and dihydrocaffeic acid, followed by sulfation, possibly in the liver, because the large intestine is not a site for the in vivo sulfation of flavonols Mullen et al., 2006) nor phenolic acids (Poquet et al., 2008) . Once again, catechol-Omethyltransferase activity could be responsible for some conversion of caffeic acid and CQAs to ferulic acid and FQAs (Fig. 5) . Conversion of caffeic acid and ferulic acid to their respective dihydro derivatives would involve either a colonic bacterial reductase or hepatic NADPH-cytochrome P450 phase I metabolism. The timing of the appearance of dihydrocaffeic acid and dihydroferulic acid metabolites in plasma indicates the involvement of the colonic microflora rather than the liver.
Urinary excretion results in the appearance of a number of metabolites, several of them glucuronides, which were either not detected or were present in plasma in only low concentrations (Table 5 ). These include traces of dihydrocaffeic acid 3-O-glucuronide, which is a minor metabolite compared with dihydrocaffeic acid-3-O-sulfate. There is also a dihydroferulic acid-4-O-glucuronide and dihydro(iso)ferulic acid-3-O-glucuronide, which would appear to be synthesized from dihydroferulic acid via dihydro(iso)ferulic acid (Fig. 5) , although the intermediate did not accumulate in detectable amounts. Urine also contained low amounts of an additional sulfated caffeic acid metabolite, caffeic acid-4-O-sulfate. Other urinary metabolites derived from ferulic acid, most likely via the routes presented in Fig.  5 , are feruloylglycine, which was a major component, and isoferulic acid-3-O-glucuronide and traces of isoferulic acid-3-O-sulfate (Table  5 ). The absence of these metabolites in plasma make it impossible to determine whether the conversion of ferulic acid to feruloylglycine and isoferulic acid, and further metabolism of isoferulic acid to dihydro(iso)ferulic acid occurs in the small intestine or the colon. If it is the colon, then the liver is the most likely site for the subsequent glucuronidation and sulfation steps.
Based on the C max and T max values presented in Table 3 , it is evident that after consumption of coffee, quantitatively much more absorption of chlorogenic acids and their metabolites occurs in the colon than in the small intestine. Experiments are in progress feeding coffee to humans subjects with an ileostomy to obtain further information to determine exactly what sections of the metabolic pathways In a recent human study by Monteiro et al. (2007) , after an acute feed with a coffee containing 3395 mol of chlorogenic acids, 8.2-fold higher than the beverage used in the present study, plasma and urine were treated with ␤-glucuronidase/sulfatase and HPLC-MS was used to detect the presence of a range of CQAs and diCQAs in plasma, but not urine, with an over all C max of 7.7 Ϯ 2.5 M occurring 2.3 Ϯ 1.3 h after intake. There were also marked differences in the plasma pharmacokinetic profile of the individual subjects. Other than to suggest that there might be a marked dose effect, we are at a loss to explain these findings, which clearly are at marked variance with the data reported in this article and other publications on chlorogenic acid bioavailability. Similar results were obtained in a further study by this group in which 10 volunteers ingested 451 mol of chlorogenic acids contained in two capsules of green coffee extracts (Farah et al., 2008) . Chlorogenic acids in the form of CQAs and diCQAs were quantified in plasma samples with C max of 14.8 M reached after 3.1 h. Contrary to our study, they did not find any FQAs in the plasma of any subjects, despite similar amounts ingested in both studies. They also reported a recovery of CQAs and diCQAs of approximately 82% of the total amount of chlorogenic acids ingested, and there was also, unlike in the present study, unusual variations in the plasma pharmacokinetic profiles of the chlorogenic acid metabolites obtained with the individual subjects. Finally, the data obtained in the current study and summarized in Table 5 clearly show that the urinary excretion of dihydrocaffeic acid-3-O-sulfate and feruloylglycine would serve as very sensitive biomarkers for the consumption of relatively small amounts of coffee, the main source of chlorogenic acids in the human diet, and that a more detailed fingerprint could be obtained by additional analysis of 
